Recordati Industria Chimica e Farmaceutica S.p.A. (RICFY)
OTCMKTS
· Delayed Price · Currency is USD
14.18
+0.34 (2.46%)
Apr 17, 2025, 4:00 PM EDT
RICFY Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Revenue | 2,342 | 2,082 | 1,853 | 1,580 | 1,449 | Upgrade
|
| Revenue Growth (YoY) | 12.45% | 12.36% | 17.29% | 9.06% | -2.23% | Upgrade
|
| Cost of Revenue | 703.78 | 600.76 | 516.93 | 427.73 | 406.83 | Upgrade
|
| Gross Profit | 1,638 | 1,482 | 1,336 | 1,152 | 1,042 | Upgrade
|
| Selling, General & Admin | 654.76 | 601.51 | 572.3 | 481.01 | 422.01 | Upgrade
|
| Research & Development | 286.03 | 255.75 | 220.1 | 166.14 | 146.24 | Upgrade
|
| Other Operating Expenses | -1.37 | -2.25 | -0.5 | 0.65 | -1.71 | Upgrade
|
| Operating Expenses | 939.42 | 855.01 | 791.91 | 647.8 | 566.55 | Upgrade
|
| Operating Income | 698.36 | 626.56 | 544.47 | 504.55 | 475.49 | Upgrade
|
| Interest Expense | -81.16 | -74.46 | -34.45 | -20.9 | -17.5 | Upgrade
|
| Interest & Investment Income | 5.96 | 4.18 | - | - | 0.02 | Upgrade
|
| Currency Exchange Gain (Loss) | -9.34 | 2.16 | -5.8 | -5.82 | 4.28 | Upgrade
|
| EBT Excluding Unusual Items | 613.82 | 558.44 | 504.22 | 477.83 | 462.29 | Upgrade
|
| Merger & Restructuring Charges | -45.43 | -67.95 | -93.47 | -11.73 | - | Upgrade
|
| Asset Writedown | -14.33 | -0.37 | -10.93 | -0.05 | - | Upgrade
|
| Other Unusual Items | -6.87 | 0.91 | 1.62 | -2.69 | -6.63 | Upgrade
|
| Pretax Income | 547.18 | 491.04 | 401.44 | 463.35 | 455.66 | Upgrade
|
| Income Tax Expense | 130.68 | 101.82 | 89.1 | 77.38 | 100.63 | Upgrade
|
| Earnings From Continuing Operations | 416.51 | 389.21 | 312.34 | 385.97 | 355.03 | Upgrade
|
| Minority Interest in Earnings | - | - | - | - | -0.04 | Upgrade
|
| Net Income | 416.51 | 389.21 | 312.34 | 385.97 | 354.98 | Upgrade
|
| Net Income to Common | 416.51 | 389.21 | 312.34 | 385.97 | 354.98 | Upgrade
|
| Net Income Growth | 7.01% | 24.61% | -19.08% | 8.73% | -3.75% | Upgrade
|
| Shares Outstanding (Basic) | 206 | 206 | 206 | 206 | 206 | Upgrade
|
| Shares Outstanding (Diluted) | 209 | 209 | 209 | 209 | 209 | Upgrade
|
| Shares Change (YoY) | -0.03% | 0.04% | -0.01% | 0.01% | -0.01% | Upgrade
|
| EPS (Basic) | 2.02 | 1.89 | 1.52 | 1.87 | 1.73 | Upgrade
|
| EPS (Diluted) | 1.99 | 1.86 | 1.49 | 1.85 | 1.70 | Upgrade
|
| EPS Growth | 7.04% | 24.57% | -19.07% | 8.72% | -3.74% | Upgrade
|
| Free Cash Flow | 533.27 | 455.63 | 437.8 | 469.8 | 382.31 | Upgrade
|
| Free Cash Flow Per Share | 2.55 | 2.18 | 2.09 | 2.25 | 1.83 | Upgrade
|
| Dividend Per Share | 1.270 | 1.200 | 1.150 | 1.100 | 1.050 | Upgrade
|
| Dividend Growth | 5.83% | 4.35% | 4.54% | 4.76% | 5.00% | Upgrade
|
| Gross Margin | 69.94% | 71.15% | 72.11% | 72.93% | 71.92% | Upgrade
|
| Operating Margin | 29.83% | 30.09% | 29.38% | 31.93% | 32.82% | Upgrade
|
| Profit Margin | 17.79% | 18.69% | 16.85% | 24.43% | 24.50% | Upgrade
|
| Free Cash Flow Margin | 22.77% | 21.88% | 23.62% | 29.73% | 26.39% | Upgrade
|
| EBITDA | 852.08 | 757.12 | 659.21 | 592.2 | 558.98 | Upgrade
|
| EBITDA Margin | 36.39% | 36.36% | 35.57% | 37.48% | 38.58% | Upgrade
|
| D&A For EBITDA | 153.72 | 130.56 | 114.73 | 87.65 | 83.49 | Upgrade
|
| EBIT | 698.36 | 626.56 | 544.47 | 504.55 | 475.49 | Upgrade
|
| EBIT Margin | 29.83% | 30.09% | 29.38% | 31.93% | 32.82% | Upgrade
|
| Effective Tax Rate | 23.88% | 20.74% | 22.20% | 16.70% | 22.08% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.